Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mazumdar

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-upL M Minasian, R J Motzer, L Gluck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapyM Mazumdar, D F Bajorin, J Bacik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicityR J Motzer, M Mazumdar, G J Bosl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancerW K Kelly, H I Scher, M Mazumdar, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|October 12, 2011
Complications after patello-femoral versus total knee replacement in the treatment of isolated patello-femoral osteoarthritis. A meta-analysisC J Dy, N Franco, Y Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survivalJ A McCaffrey, M Mazumdar, D F Bajorin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Advanced seminoma: treatment results, survival, and prognostic factors in 142 patientsP J Mencel, R J Motzer, M Mazumdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary siteR J Motzer, E Rodriguez, V E Reuter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Metastatic germ cell tumors: modeling for response to chemotherapyD F Bajorin, M Mazumdar, M Meyers, et al.
Cancer Research|December 1, 1993
Allelic deletions in renal tumors: histopathological correlationsJ C Presti, V E Reuter, C Cordon-Cardo, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-upL M Minasian, R J Motzer, L Gluck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapyM Mazumdar, D F Bajorin, J Bacik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicityR J Motzer, M Mazumdar, G J Bosl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancerW K Kelly, H I Scher, M Mazumdar, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|October 12, 2011
Complications after patello-femoral versus total knee replacement in the treatment of isolated patello-femoral osteoarthritis. A meta-analysisC J Dy, N Franco, Y Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survivalJ A McCaffrey, M Mazumdar, D F Bajorin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Advanced seminoma: treatment results, survival, and prognostic factors in 142 patientsP J Mencel, R J Motzer, M Mazumdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary siteR J Motzer, E Rodriguez, V E Reuter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Metastatic germ cell tumors: modeling for response to chemotherapyD F Bajorin, M Mazumdar, M Meyers, et al.
Cancer Research|December 1, 1993
Allelic deletions in renal tumors: histopathological correlationsJ C Presti, V E Reuter, C Cordon-Cardo, et al.
Pageof 11